Current:Home > reviewsAI fever drives Nvidia to world's most valuable company, over Microsoft and Apple -TrueNorth Capital Hub
AI fever drives Nvidia to world's most valuable company, over Microsoft and Apple
View
Date:2025-04-18 04:03:05
- Nvidia shares rose 3.5% on Tuesday, giving it a market value of about $3.34 trillion.
- The surge in Nvidia's market value has been driven by demand for its chips, which are the gold standard in the AI space.
- Nvidia's impressive financial performance and forecasts have led its stock valuation, by some measures, to moderate despite the surge in its share price.
NEW YORK — Nvidia has become the world’s most valuable company following a staggering rally in its shares, underlining the outsized role investors expect artificial intelligence to play in the global economy over coming years.
Nvidia shares rose 3.5% on Tuesday, giving it a market value of about $3.34 trillion. That pushed the semiconductor bellwether past Microsoft and Apple, which had been jostling for the top spots in recent days.
The surge in Nvidia's market value has been driven by demand for its chips, which are the gold standard in the AI space. The company's shares are up more than 170% this year and have risen about 1,100% since their October 2022 low.
Blockbuster earnings and broadening investor enthusiasm over AI are supercharging Nvidia's rally. That fervor has been reflected in Nvidia’s market value, which took only 96 days to go from $2 trillion to $3 trillion.
How far will it go?Nvidia (NVDA) stock forecast and price target prediction
Microsoft, one of the two other companies to reach those rarefied levels, took 945 days to go from $2 trillion to $3 trillion while Apple took 1,044 days to make the leap, according to Bespoke Investment Group.
Previously, just 11 U.S. companies since 1925 have reached the top spot in market value on a closing basis, according to Howard Silverblatt, senior index analyst at S&P Dow Jones Indices.
Fortunes have diverged for past holders of the top position in recent decades. Microsoft reached No. 1 in the late 1990s but then its shares struggled for years during the early 2000s following the dotcom bubble, only to come roaring back in the latter half of the last decade.
Exxon Mobil became the world’s most valuable company in the 2000s but its shares retreated following a downturn in oil prices.
To some, Cisco is the cautionary tale. The company’s shares peaked at over $80 in March 2000 in the midst of the dotcom boom, during which investors often assigned dizzying valuations to internet-related companies.
Bespoke’s analysts recently contrasted the trajectories of Nvidia and Cisco, whose products were seen as essential in supporting the internet's infrastructure.
"NVDA's run has been incredible, but it will need to keep growing from here and stave off competition if its stock is going to keep putting up stellar returns," Bespoke said in a recent note.
In court:Supreme Court to hear Nvidia bid to scuttle shareholder lawsuit
For now, Nvidia’s earnings are supporting its stock price. Revenue more than tripled to $26 billion in the latest quarter, while net income jumped seven-fold to $14.9 billion.
Revenue for the current fiscal year is expected to roughly double to $120 billion, and then rise another 33% in fiscal 2026, to $160 billion, according to LSEG data.
Nvidia's impressive financial performance and forecasts have led its stock valuation, by some measures, to moderate despite the surge in its share price.
For example, Nvidia's forward price-to-earnings ratio last stood at 43, according to LSEG Datastream. That is higher than the 25 level it stood at to start the year but below levels it reached for much of last year. By contrast, the S&P 500 trades at 21 times earnings.
While Nvidia has been the standout performer, it is not the only stock to benefit from enthusiasm about the profit potential for AI. Shares of other technology companies, including Super Micro Computer and Arm Holdings, have also risen sharply this year.
Reporting by Lewis Krauskopf in New York. Additional reporting by Saqib Iqbal Ahmed in New York and Noel Randewich in Oakland, California. Editing by Ira Iosebashvili and Matthew Lewis.
veryGood! (4)
Related
- Federal hiring is about to get the Trump treatment
- Diabetes and obesity are on the rise in young adults, a study says
- Trump’s EPA Fast-Tracks a Controversial Rule That Would Restrict the Use of Health Science
- A doctor near East Palestine, Ohio, details the main thing he's watching for now
- In ‘Nickel Boys,’ striving for a new way to see
- This is the period talk you should've gotten
- Democratic state attorneys general sue Biden administration over abortion pill rules
- North Carolina’s Goal of Slashing Greenhouse Gases Faces Political Reality Test
- EU countries double down on a halt to Syrian asylum claims but will not yet send people back
- Biden to name former North Carolina health official Mandy Cohen as new CDC director
Ranking
- Federal Spending Freeze Could Have Widespread Impact on Environment, Emergency Management
- Idaho dropped thousands from Medicaid early in the pandemic. Which state's next?
- Spills on Aging Enbridge Pipeline Have Topped 1 Million Gallons, Report Says
- Frozen cells reveal a clue for a vaccine to block the deadly TB bug
- Charges tied to China weigh on GM in Q4, but profit and revenue top expectations
- To safeguard healthy twin in utero, she had to 'escape' Texas for abortion procedure
- First Water Tests Show Worrying Signs From Cook Inlet Gas Leak
- Arizona to halt some new home construction due to water supply issues
Recommendation
Gen. Mark Milley's security detail and security clearance revoked, Pentagon says
Australian airline rolls out communal lounge for long-haul flights
Britney Spears Makes Rare Comment About Sons Jayden James and Sean Preston Federline
These 6 tips can help you skip the daylight saving time hangover
The company planning a successor to Concorde makes its first supersonic test
Germany’s Nuke Shutdown Forces Utility Giant E.ON to Cut 11,000 Jobs
Texas Gov. Abbott signs bill banning transgender athletes from participating on college sports teams aligned with their gender identities
Experts weigh medical advances in gene-editing with ethical dilemmas